147 related articles for article (PubMed ID: 1432567)
1. Activation of the complement system by (1----3)-beta-D-glucans having different degrees of branching and different ultrastructures.
Suzuki T; Ohno N; Saito K; Yadomae T
J Pharmacobiodyn; 1992 Jun; 15(6):277-85. PubMed ID: 1432567
[TBL] [Abstract][Full Text] [Related]
2. Application of limulus test (G pathway) for the detection of different conformers of (1-->3)-beta-D-glucans.
Nagi N; Ohno N; Adachi Y; Aketagawa J; Tamura H; Shibata Y; Tanaka S; Yadomae T
Biol Pharm Bull; 1993 Sep; 16(9):822-8. PubMed ID: 8268846
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of clot formation of human plasma by beta-glucans.
Ohno N; Suzuki T; Saito K; Yadomae T
J Pharmacobiodyn; 1990 Sep; 13(9):525-32. PubMed ID: 2084223
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of Limulus amoebocyte lysate towards (1----3)-beta-D-glucans.
Ohno N; Emori Y; Yadomae T; Saito K; Masuda A; Oikawa S
Carbohydr Res; 1990 Oct; 207(2):311-8. PubMed ID: 2076521
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro.
Okazaki M; Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1995 Oct; 18(10):1320-7. PubMed ID: 8593430
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological activities of sulfated derivatives of (1----3)-beta-D-glucans.
Suzuki T; Ohno N; Adachi Y; Cirelli AF; Covian JA; Yadomae T
J Pharmacobiodyn; 1991 May; 14(5):256-66. PubMed ID: 1770430
[TBL] [Abstract][Full Text] [Related]
7. Activation of limulus coagulation factor G by several (1-->3)-beta-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations.
Aketagawa J; Tanaka S; Tamura H; Shibata Y; Saitô H
J Biochem; 1993 Jun; 113(6):683-6. PubMed ID: 8370664
[TBL] [Abstract][Full Text] [Related]
8. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice.
Tsuzuki A; Tateishi T; Ohno N; Adachi Y; Yadomae T
Biosci Biotechnol Biochem; 1999 Jan; 63(1):104-10. PubMed ID: 10052129
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the blood clearance of triple- and single-helical schizophyllan in mice.
Miura NN; Ohno N; Adachi Y; Aketagawa J; Tamura H; Tanaka S; Yadomae T
Biol Pharm Bull; 1995 Jan; 18(1):185-9. PubMed ID: 7735240
[TBL] [Abstract][Full Text] [Related]
10. The cytokine stimulating activity of (1-->3)-beta-D-glucans is dependent on the triple helix conformation.
Falch BH; Espevik T; Ryan L; Stokke BT
Carbohydr Res; 2000 Nov; 329(3):587-96. PubMed ID: 11128587
[TBL] [Abstract][Full Text] [Related]
11. The correlation between adhesion of schizophyllan to yeast glucan and its effect on regeneration of yeast protoplast.
Hisamatsu M; Mishima T; Teranishi K; Yamada T
Carbohydr Res; 1997 Feb; 298(1-2):117-21. PubMed ID: 9076934
[TBL] [Abstract][Full Text] [Related]
12. Relationship between conformation and biological response for (1----3)-beta-D-glucans in the activation of coagulation factor G from limulus amebocyte lysate and host-mediated antitumor activity. Demonstration of single-helix conformation as a stimulant.
Saitô H; Yoshioka Y; Uehara N; Aketagawa J; Tanaka S; Shibata Y
Carbohydr Res; 1991 Sep; 217():181-90. PubMed ID: 1797400
[TBL] [Abstract][Full Text] [Related]
13. Curdlan, a (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO13140, activates the alternative complement pathway by heat treatment.
Matsushita M
Immunol Lett; 1990 Oct; 26(1):95-7. PubMed ID: 2276766
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
Honda S; Sugino H; Asano T; Kakinuma A
Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics studies of side chain effect on the beta-1,3-D-glucan triple helix in aqueous solution.
Okobira T; Miyoshi K; Uezu K; Sakurai K; Shinkai S
Biomacromolecules; 2008 Mar; 9(3):783-8. PubMed ID: 18257529
[TBL] [Abstract][Full Text] [Related]
16. Preparation and antigen specificity of an anti-(1-->3)-beta-D-glucan antibody.
Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Nov; 17(11):1508-12. PubMed ID: 7703974
[TBL] [Abstract][Full Text] [Related]
17. Observation of a partially opened triple-helix conformation in 1-->3-beta-glucan by fluorescence resonance energy transfer spectroscopy.
Young SH; Dong WJ; Jacobs RR
J Biol Chem; 2000 Apr; 275(16):11874-9. PubMed ID: 10766814
[TBL] [Abstract][Full Text] [Related]
18. The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line.
Mueller A; Raptis J; Rice PJ; Kalbfleisch JH; Stout RD; Ensley HE; Browder W; Williams DL
Glycobiology; 2000 Apr; 10(4):339-46. PubMed ID: 10764821
[TBL] [Abstract][Full Text] [Related]
19. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
Czop JK; Austen KF
J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
[TBL] [Abstract][Full Text] [Related]
20. The effect of (1-->3)-beta-D-glucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro.
Kubala L; Ruzickova J; Nickova K; Sandula J; Ciz M; Lojek A
Carbohydr Res; 2003 Nov; 338(24):2835-40. PubMed ID: 14667704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
